DAFTAR PUSTAKA

1. Ansong-Assoku B, Ankola PA. Neonatal Jaundice. 2018 [diakses tanggal 5

Oktober 2019]. Tersedia di: https://www.ncbi.nlm.nih.gov/books/NBK65119/

2. Queensland Government. Maternity and Neonatal Clinical Guideline Neonatal

respiratory distress including CPAP. 2014 [diakses tanggal 5 Oktober 2019].

Tersedia di: www.health.qld.gov.au/qcg

3. Ramachandran A. Neonatal hyperbilirubinaemia. J Paediatr Child Health.

2015;26:162–8.

4. Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: types, causes,

clinical examinations, preventive measures and treatments: a narrative review

article. Iran J Public Health. 2016;45:558–68.

5. Sukadi A. Hiperbilirubinemia. Dalam: Kosim M, Yunanto A, Dewi R, Sarosa G,

Usman A, penyunting. Buku ajar neonatologi. Edisi Pertama. Jakarta: Badan

Penerbit IDAI; 2014. h. 147–169

6. Zanardo V, Simbi AK, Parotto M, Guerrini P, Severino L, Ferro S, dkk. Umbilical

cord bilirubin level and pre-discharge hyperbilirubinemia risk. J Matern Neonatal

Med. 2019;0:1–7.

7. Mwaniki M, Gatakaa H, Mturi F, Chesaro C, Chuma J, Peshu N, dkk. An increase

in the burden of neonatal admissions to a rural district hospital in Kenya over 19

years. BMC Public Health. 2010;10:591.

8. Ben M, Gazzin S, Tiribelli C. Neonatal hyperbilirubinemia. Ital J Pediatr.

2014;40:10–5.

9. Nurani N, Kadi F, Rostini A. Incidence of neonatal hyperbilirubinemia based on

45
 their characteristics at Dr. Hasan Sadikin General Hospital Bandung Indonesia.

2017;4:431–4.

10. Wong R, Stevenson D, Ahlfors C, Vreman H. Neonatal jaundice bilirubin

physiology and clinical chemistry. Neoreviews. 2007;8:58–67.

11. Young P, Korgenski K, Buchi K. Early readmission of newborns in a large health

care system. Pediatrics. 2013;131:1538–44.

12. Jones KDJ, Grossman SE, Kumaranayakam D, Rao A, Fegan G, Aladangady N.

Umbilical cord bilirubin as a predictor of neonatal jaundice: a retrospective cohort

study. BMC Pediatr. 2017;17:1–6.

13. Han S, Yu Z, Liu L, Wang J, Wei Q, Jiang C, dkk. A model for predicting

significant hyperbilirubinemia in neonates from China. Pediatrics. 2015;136:896–

905.

14. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.

Management of hyperbilirubinemia in the newborn infant 35 or more weeks of

gestation. Pediatrics. 2004;114:297–316.

15. Perlman JM, Volpe JJ. Bilirubin. Dalam: Volpe JJ, Darras BT, Inder TE. Volpe’s

neurology of the newborn. Philadelphia: Elsevier Inc; 2017. h. 730–62

16. Hall J. The liver as an organ. Dalam: Hall JE, Guyton AC. Textbook of medical

physiology. Edisi Ke-13. Philadelphia: Elsevier Inc; 2016. h. 881–6

17. Dewanto N, Dewi R. Hiperbilirubinemia. Dalam: Pudjiaji A, Hegar B,

Handryastuti S, Idris N, Gandaputra E, Harmoniati E, dkk, penyunting. Pedoman

pelayanan medis Ikatan Dokter Anak Indonesia. Edisi Kedua. Jakarta: Badan

Penerbit IDAI; 2011. h. 114–22

18. UKK Neonatologi IDAI. Hiperbilirubinemia. Dalam: Iskandar A, Handayani K,

46
 Wilar R, Lusyati S, Yuniati T, Hendrarto T, dkk, penyunting. Buku panduan

pelayanan neonatal. Jakarta: Badan Penerbit IDAI; 2018. h. 356–472

19. Blackburn ST. Bilirubin metabolism. Dalam: Blackburn ST. Maternal, fetal and

neonatal physiology: a clinical perspective. Edisi Ketiga. Missouri: Saunders;

2007. h. 643-9.

20. Direktorat Jenderal Bina Gizi dan Kesehatan Ibu dan Anak Kementrian Kesehatan

RI. Buku saku pelayanan kesehatan neonatal esensial: pedoman teknis pelayanan

kesehatan dasar. Jakarta: Kementrian Kesehatan Republik Indonesia; 2012. h. 134

21. Greco C, Arnolda G, Boo NY, Iskander IF, Okolo AA, Rohsiswatmo R, dkk.

Neonatal jaundice in low and middle income countries: lessons and future

directions from the 2015 Don Ostrow Trieste Yellow Retreat. Neonatology.

2016;110:172–80.

22. Dijk P, de Vries T, de Beer J, Dutch Pediatric Association. Guideline prevention,

diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age

of 35 or more weeks. Ned Tijdschr Geneeskd. 2009;153:93.

23. National Institute for Health and Clinical Excellence. Neonatal jaundice. Dalam:

Welsh A, penyunting. Clinical Guideline. London: Royal College of Obstetricians

and Gynaecologists; 2016. h. 33-70

24. WHO Europe. Neonatal Jaundice Module 4N Learning Objectives. Dalam:

Asatiani T, Berdzuli N, Chernov A, Chiaffoni G, Dianskyi D, dkk. Effective

Perinatal Care (EPC) training package. Edisi Kedua. Denmark: WHO Europe;

2015. h. 1N3-7N24

25. Mamyrbaeva MA, Zhumagalieva GD. Keeping babies with jaundice syndrome in

primary health care. Biomed Pharmacol J. 2017;10:173–8.

47
26. Donneborg M, Vandborg P, Hansen B, Rodrigo-Domingo, M Ebbesen F. Double

versus single intensive phototherapy with LEDs in treatment of neonatal

hyperbilirubinemia. J Perinatol. 2018;38:154.

27. Rohsiswatmo R, Amandito R. Hiperbilirubinemia pada neonatus >35 minggu di

Indonesia; pemeriksaan dan tatalaksana terkini. Sari Pediatri. 2018;20:115.

28. Vreman H, Slusher T, Wong R, Schulz S, Olusanya B, Stevenson D. Evaluation of

window-tinting films for sunlight phototherapy. J Trop Pediatr. 2013;59:496–501.

29. Stevenson D, Wong R. Metalloporphyrins in the management of neonatal

hyperbilirubinemia. Semin Fetal Neonatal Med. 2010;15:164–8.

30. Sharafi R, Mortazavi Z, Sharafi S, Parashkouh R. The effect of clofibrate on

decreasing serum bilirubin in healthy term neonates under home phototherapy. Iran

J Pediatr. 2010;20:48.

31. Watchko J, Tiribelli C. Bilirubin-induced neurologic damage - mechanisms and

management approaches. N Engl J Med. 2013;369:2021–30.

32. Wong RJ, Bhutani VK. Treatment of unconjugated hyperbilirubinemia in term and

late preterm infants. Uptodate. 2013;1–21.

33. American Academy of Pediatrics. Phototherapy to prevent severe neonatal

hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Pediatrics. 2011;128:763–5.

34. Harsha L, Priya J, Khushali K, Reshmi B. Systemic approach to management of

neonatal jaundice and prevention of kernicterus. Res J Pharm Technol.

2015;8:1087–92.

35. Ramasethu J, Luban N. Alloimmune hemolytic disease of the newborn. Dalam:

Lichtman M, Beutler E, Kipps T, Seligsohn U, Kaushansky K, Prchal J,

48
 penyunting. Williams Hematology. Edisi Ketujuh. New York: McGraw-Hill;

2006. h. 715–66.

36. Bhutani VK, Wong RJ, Stevenson DK. Hyperbilirubinemia in Preterm Neonates.

Clin Perinatol. 2016;43:215–32.

37. Bhutani VK, Vilms R, Hamerman-Johnson L. Universal bilirubin screening for

severe neonatal hyperbilirubinemia. J Perinatol. 2010;30:6–15.

38. Watchko J, Tiribelli C. Bilirubin-induced neurologic damage. N Engl J Med.

2014;370:979.

39. Hansen T. Prevention of neurodevelopmental sequelae of jaundice in the newborn.

Dev Med Child Neurol. 2011;53:24–8.

40. Brites D, Brito A. Bilirubin toxicity. Dalam: Stevenson D, Maisels M, Watchko J,

penyunting. Neonatal jaundice. New York: The McGraw Hill Companies; 2012.

h. 115–43

41. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the

management of hyperbilirubinemia in the preterm infant less than 35 weeks of

gestation. J Perinatol. 2012;32:660–4.

42. Ramamoorthy K, Abilash MS. Cord blood bilirubin used as an early predictor of

hyperbilirubinemia. Int J Contemp Pediatr. 2018;5:1280-5.

43. Castillo A, Grogan TR, Wegrzyn GH, Ly K V, Walker P, Calkins KL. Umbilical

cord blood bilirubins, gestational age, and maternal race predict neonatal

hyperbilirubinemia. 2018;20:1–12.

44 Ipek I, Bozaykut A, Cagril S, Sezer R. Does cord blood bilirubin level help the

physician in the decision of early postnatal discharge? J Matern Fetal Neonatal

Med. 2012;8:1375-8.

49
45. Knüpfer M, Pulzer F, Gebauer C, Robel-Tillig E, Vogtmann C. Predictive value of

umbilical cord blood bilirubin for postnatal hyperbilirubinaemia. Acta Paediatr.

2007;94:581–7.

46. Aktas S, Dogan C, Okmen ZH, Gulec SG. Is cord blood bilirubin level a reliable

predictor for developing significant hyperbilirubinemia? Am J Perinatol.

2018;36:317–21.

47. Baskar C, Babu ASKK, Anandan H. To study the predictive value of umbilical

cord bilirubin in neonatal hyperbilirubinemia. J Int Med Res. 2018;5:1–5.

48. Garg DA. Umbilical Cord Bilirubin-an Early Diagnostic Marker of Significant

Neonatal Hyperbilirubinemia. J Med Sci Clin Res. 2017;5:20345–9.

49. Calkins K, Roy D, Molchan L, Bradley L, Grogan T, Elashoff D, dkk. Predictive

value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for

maternal-fetal blood group incompatibility and hemolytic disease of the newborn.

J Neonatal Perinatal Med. 2015;8:243–50.

50. Bhat JA. Pediatrics and neonatal biology open access correlation of cord blood

bilirubin values with neonatal jaundice in health newborns : a prospective

observational study. Pediatr Neonat biol. 2018;1-6.

51. Alalfy M, lithy A el, EzzEldin ZM, Mansi YA, Hamed A, Mostofa MB, dkk. Role

of bilirubin and albumin in cord blood as predictors for neonatal

hyperbilirubinemia. J Gynecol Res. 2018;4:1-14.

52. Peeters B, Geerts I, Van Mullem M, Micalessi I, Saegeman V, Moerman J. Post-

test probability for neonatal hyperbilirubinemia based on umbilical cord blood

bilirubin, direct antiglobulin test, and ABO compatibility results. Eur J Pediatr.

2016;175:651–7.

50
53. Hemmati F, Hashemi Z. Evaluation of the predictive value of umbilical cord serum

bilirubin level for the development of subsequent hyperbilirubinemia in term and

late-preterm neonates. Iran J Neonatol. 2016;7:25–31.

51